Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses

British Journal of Psychiatry

Volumn 172, Issue JUNE, 1998, Pages 499-505

  Tran, P V ^a   Dellva, M A ^a   Tollefson, G D ^a   Wentley, A L ^a   Beasley Jr , C M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; ORAL DRUG ADMINISTRATION; PSYCHOSIS; RATING SCALE; RELAPSE; SCHIZOPHRENIA;

EID: 0031836975     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.172.6.499     Document Type: Article

References (23)

1. Beasley, C. M., Jr, Sanger, T., Satterlee, W., et al (1996a) Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology, 124, 159-167.
2. _ , Tollefson, G., Tran, P. V., et al (1996b) Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial. Neuropsychophormacology, 14, 111-123.
3. _, Hamilton, S., Crawford, A. M., et al (1997) Olanzapine versus haloperidol: Acute-phase results of the international double-blind olanzapine trial. European Neuropsychopharmacology, 7, 125-137.
4. Carpenter, W. T., Hanlon, T. E., Heinrichs, D. W., et al (1990) Continuous versus targeted medication in schizophrenic out-patients: outcome results. American Journal of Psychiatry, 147, 1138-1148.
5. Crow, T. J., Macmillan, J. F., Johnson, A. L., et al (1986) A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120-127.
6. Davis, J. M., Kane, J. M., Marder, S. R., et al (1993) Dose response of prophylactic antipsychotics. Journal of Clinical Psychiatry, Suppl. 54, 24-30.
7. Dellva, M. A., Tran, P. V. Tollefson, G. D., et al (1997) Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia. Psychiatric Services, 48, 1571-1577.
8. Gilbert, P. L., Harris, M. J., McAdams, L. A., et al (1995) Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry, 52, 173-188.
9. Goldstein, M. J., Rodnick, E. H., Evans, J. R., et al (1978) Drug and family therapy in the aftercare of acute schizophrenics. Archives of General Psychiatry, 35, 1169-1177.
10. Greenhouse, J. B. & Meyer, M. M. (1991) A note on randomisation and selection bias in maintenance therapy clinical trials. Psychopharmacology Bulletin, 27, 225-229.
11. _, Stangl, D., Kupfer, D. J., et of (1991) Methodologic issues in maintenance therapy clinical trials. Archives of General Psychiatry, 48, 313-318.
12. Herz, M. I., Glazer, W. M., Mostert, N. A., et al (1991) Intermittent vs maintenance medication in schizophrenia. Archives of General Psychiatry, 48, 333-339.
13. Hogarty, G. E., McEvoy, J. P., Munitz, M., et al (1988) Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Archives of General Psychiatry, 45, 797-805.
14. Johnson, D. A. W., Ludlow, J. M., Street, K., et al (1987) Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia. British Journal of Psychiatry, 151, 634-638.
15. Jolley, A. G., Hirsch, S. R., McRink, A., et al (1989) Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. British Journal of Psychiatry, 208, 985-990.
16. Kane, J. M. (1983) Low dose medication strategies in the maintenance treatment of schizophrenia. Schizophrenia Bulletin, 9, 528-532.
17. _ & Marder, S. R. (1993) Psychopharmacologic treatment of schizophrenia. (Review). Schizophrenia Bulletin, 19, 287-302.
18. Marder, S. R., Van Putten, T., Mintz, J., et al (1984) Costs and benefits of two doses of fluphenazine. Archives of General Psychiatry, 41, 1025-1029.
19. _, _ & _ (1987) Low- and conventional-dose maintenance therapy with fluphenazine decanoate: Two-year outcome. Archives of General Psychiatry, 44, 513-521.
20. Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
21. Pietzcker, A., Gaebel, W. & Köpeke, W. (1993) Intermittent versus maintenance neuroleptic long-term treatment in schizophrenia: 2-year results of a German multicenter study. Journal of Psychiatric Research, 27, 321-339.
22. SAS Institute Inc (1990) SAS/STAT User's Guide. Cary, NC: SAS Institute Inc.
23. Tollefson, G. D., Beasley, C. M., Jr, Tran, P. V., et al (1997) Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry 154, 457-465.